Unity Biotechnology Is A Biotechnology Company Dedicated To Developing Innovative Therapeutics That Target Aging Related Diseases Through The Science Of Cellular Senescencethe Company Focuses On Creating Medicines For Chronic And Inflammatory Conditionsparticularly In The Field Of Ophthalmologywith An Emphasis On Diabetic Macular Edemadmeone Of Their Key Productsubx1325Is A Senolytic Small Molecule Inhibitor Designed To Clear Senescent Cellspotentially Offering Longer Lasting Vision Improvement Compared To Standard Treatmentsthe Company Is Conducting Clinical Trialsincluding The Phase 2 Behold Studywhich Has Shown Significant Vision Improvement In Dme Patients After A Single Injectionunity S Approach Includes Localized Delivery Methods To Reduce Systemic Side Effects The Leadership Team At Unity Comprises Experienced Professionals In Aging Biology And Drug Developmentfostering A Culture Of Innovation And Collaborationthe Company Aims To Meet The Needs Of Patients With Retinal Diseases By Enhancing Treatment Durability And Efficacy
